New iPS cell conventional wisdom from polls: epigenetics & mutations remain concerns, immunogenicity not so much
I recently did a series of 4 polls on potential roadblock issues in the iPS cell field. The impetus for these polls was my sense that there were substantial differences in views on whether iPS cells were now proven to be equivalent to ES cells in 4 key ways. Turns out the polls got a …